Arcutis biotherapeutics stock.

May 9, 2023 · ARCUTIS BIOTHERAPEUTICS, INC. Condensed Balance Sheets (In thousands) March 31, December 31, 2023 2022 (unaudited) ASSETS Current assets: Cash and cash equivalents $ 81,405 $ 53,641 Restricted cash 925 1,234 Trade receivable, net 12,769 8,458 Marketable securities 251,000 355,948 Inventories 8,551 As of September 29, 2023, 4:00 PM, CST, Arcutis Biotherapeutics Inc’s stock price was $5.31. Arcutis Biotherapeutics Inc is down 4.15% from its previous closing price of $5.54. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $5.33 and $5.70. Currently, there are 61.43 million shares of Arcutis ...Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of patients living with immune-mediated ...Complete Arcutis Biotherapeutics Inc. stock information by Barron's. View real-time ARQT stock price and news, along with industry-best analysis.

Morgan Stanley analyst Vikram Purohit maintained a Buy rating on Arcutis Biotherapeutics ( ARQT – Research Report) today and set a price target of $50.00. The company’s shares closed yesterday ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is an early commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with ...

Mizuho Securities analyst Uy Ear maintained a Buy rating on Arcutis Biotherapeutics ( ARQT – Research Report) today and set a price target of $61.00. The company’s shares opened today at $13. ...Mizuho Securities analyst Uy Ear maintained a Buy rating on Arcutis Biotherapeutics ( ARQT – Research Report) today and set a price target of $61.00. The company’s shares opened today at $13. ...Arcutis Biotherapeutics Inc. Watch list Set a price target alert Open Last Updated: Dec 1, 2023 1:02 p.m. EST Real time quote $ 1.9450 0.1050 5.71% Previous Close $1.8400 …On average, Wall Street analysts predict that Arcutis Biotherapeutics's share price could reach $21.33 by Nov 13, 2024. The average Arcutis Biotherapeutics ...Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is an early commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with ...

As of March 07, 2023, 4:00 PM CST, Arcutis Biotherapeutics Inc’s stock price was $13.69. Arcutis Biotherapeutics Inc is down 5.85% from its previous closing price of $14.54. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $14.43 and $15.47. Currently, there are 61.04 million shares of Arcutis ...

See the latest Arcutis Biotherapeutics Inc Ordinary Shares stock price (ARQT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Nov 8, 2022 · The replay of the webcast will be available on the Arcutis website following the call. About Arcutis . Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of patients living with immune-mediated dermatological diseases and conditions. Jul 12, 2023 · Recent developments: Arcutis Biotherapeutics' stock rose 15% in early June after prescription data showed a 40% increase in Q1 for their psoriasis cream, Zoryve. Q1 2023 Earnings. Feb 9, 2023 · Arcutis is building momentum around its Zoryve segment with a string of recent advancements at the back end of FY22 and into the new year. Find out why ARQT stock is a Buy. Arcutis Biotherapeutics reported an EPS of -$0.73 in its last earnings report, beating expectations of -$0.914. Following the earnings report the stock price went up 9.91%. Which hedge fund is a major shareholder of Arcutis Biotherapeutics?Get Arcutis Biotherapeutics Inc (ARQT.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.

Arcutis Biotherapeutics Inc is down 6.97% from its previous closing price of $7.82. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $7.82 and $8.26. Currently, there are 61.43 million shares of Arcutis Biotherapeutics Inc stock available for purchase. Unfortunately, Arcutis Biotherapeutics Inc’s P/E ratio ...Arcutis Biotherapeutics, Inc. is a medical dermatology company. The Company is focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its portfolio is comprised of topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions.Phone Number 805-418-5006. Arcutis Biotherapeutics is a privately held clinical-stage biopharmaceutical company focused on developing and commercializing treatments for …Latest News. November 15, 2022. Get Arcutis Biotherapeutics Inc (ARQT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.66.61%. Get the latest Arcutis Biotherapeutics Inc (ARQT) real-time quote, historical performance, charts, and other financial information to help you make more informed …

Arcutis Biotherapeutics, Inc. (ARQT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

According to 6 analyst offering 12-month price targets in the last 3 months, Arcutis Biotherapeutics has an average price target of $42.17 with a high of $57.00 and a low of $22.00.Description. Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment ...Earlier this month, the company added to its pipeline assets by acquiring privately held Ducentis Biotherapeutics for an upfront cash payment of ~$16 million and Arcutis stock valued at ~$14 ...Dec 1, 2023About Arcutis Biotherapeutics Inc. Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical ...Arcutis is in process of establishing Canadian operations; WESTLAKE VILLAGE, Calif., July 11, 2022 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), today announced that Health Canada has accepted for review the New Drug Submission (NDS) for roflumilast cream 0.3% for the treatment of plaque psoriasis in adults and …

According to 6 analyst offering 12-month price targets in the last 3 months, Arcutis Biotherapeutics has an average price target of $42.17 with a high of $57.00 and a low of $22.00.

Since the trade, Arcutis Biotherapeutics Inc's stock has declined by 20.89%, and it has plummeted by 91.54% since its IPO. The year-to-date performance is also down by 86.8%. With no applicable GF ...

Arcutis Biotherapeutics Inc is down 6.97% from its previous closing price of $7.82. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $7.82 and $8.26. Currently, there are 61.43 million shares of Arcutis Biotherapeutics Inc stock available for purchase. Unfortunately, Arcutis Biotherapeutics Inc’s P/E ratio ...As of March 06, 2023, 4:00 PM CST, Arcutis Biotherapeutics Inc’s stock price was $14.54. Arcutis Biotherapeutics Inc is down 6.5% from its previous closing price of $15.55. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $15.55 and $16.45. Currently, there are 61.04 million shares of Arcutis ...Get a real-time Arcutis Biotherapeutics, Inc. (ARQT) stock price quote with breaking news, financials, statistics, charts and more.Arcutis Biotherapeutics - ARQT - Stock Price Today - Zacks Arcutis Biotherapeutics (ARQT) (Real Time Quote from BATS) $1.99 USD +0.03 (1.53%) Updated Nov 28, 2023 10:40 AM ET Add to...The Arcutis Biotherapeutics Inc stock price fell by -6.86% on the last day (Wednesday, 29th Nov 2023) from $2.04 to $1.90.During the last trading day the stock fluctuated 20.00% from a day low at $1.88 to a day high of $2.25.The price has fallen in 6 of the last 10 days and is down by -12.84% for this period. Volume has increased on the …What this means: InvestorsObserver gives Arcutis Biotherapeutics Inc (ARQT) an overall rank of 33, which is below average. Arcutis Biotherapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 33 means that 67% of stocks appear more favorable to our system.Shares of Arcutis Biotherapeutics ( ARQT -3.16%) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology ...Nov 30, 2023 · Arcutis Announces Pricing of $100 Million Public Offering. WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) (“Arcutis”), an early commercial-stage biopharmaceutical company focused on developing meaningf... 4 weeks ago - GlobeNewsWire.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated ...Stock analysis for Arcutis Biotherapeutics Inc (ARQT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.1 thg 2, 2021 ... Stock of Arcutis Biotherapeutics, a Westlake Village-based company developing dermatological treatments, shot up more than 30% on Feb.Instagram:https://instagram. marc chaikin stock pickbest stocks under 20 dollarsbest online broker us index fundspremakret movers WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) (“Arcutis”), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the pricing of its underwritten public offering of common …Arcutis Biotherapeutics ( NASDAQ: ARQT) announced Tuesday that its psoriasis therapy roflumilast cream reached the primary endpoint and all secondary endpoints in a Phase 3 trial for children with ... finance betarussell 2000 value etf ARQT stock had a significant performance on November 3, 2023. According to data from CNN Money, eight analysts have offered 12-month price forecasts for Arcutis Biotherapeutics Inc, with a median target of $33.00. The high estimate for the stock price is $50.00, while the low estimate is $4.00.Arcutis Biotherapeutics (NASDAQ: ARQT) stock looks deeply undervalued after a correction of 65% in the last 12 months. However, it’s worth noting that even after the big downside, the short ... dental insurance plans in ohio Stock analysis for Arcutis Biotherapeutics Inc (ARQT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.All of the shares of common stock and pre-funded warr. WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) (“Arcutis”), an early commercial ...WESTLAKE VILLAGE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (“Arcutis”) (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced the commencement of an underwritten public offering of $150.0 ...